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Pax3, a key myogenic regulator, is transiently ex-
pressed during activation of adult muscle stem cells,
or satellite cells (SCs), and is also expressed in a
subset of quiescent SCs (QSCs), but only in specific
muscles. The mechanisms regulating these varia-
tions in expression are not well understood. Here
we show that Pax3 levels are regulated by miR-206,
a miRNA with a previously demonstrated role in
myogenic differentiation. In most QSCs and acti-
vated SCs, miR-206 expression suppresses Pax3
expression. Paradoxically, QSCs that express high
levels of Pax3 also express high levels of miR-206.
In these QSCs, Pax3 transcripts are subject to alter-
native polyadenylation, resulting in transcripts with
shorter 30 untranslated regions (30UTRs) that render
them resistant to regulation bymiR-206. Similar alter-
nate polyadenylation of the Pax3 transcript also
occurs inmyogenic progenitors during development.
Our findings may reflect a general role of alternative
polyadenylation in circumventing miRNA-mediated
regulation of stem cell function.
INTRODUCTION
Pax3 is a key regulator of myogenesis during development. In
Splotch (Sp) mice, which carry a spontaneous mutation in the
Pax3 locus, limb muscles are absent (Bober et al., 1994; Gould-
ing et al., 1994). The formation of these muscles requires Pax3
for the induction of expression of c-Met, a tyrosine kinase
receptor essential for the delamination and migration of muscle
progenitor cells (Bladt et al., 1995; Epstein et al., 1995; Yang
et al., 1996). Postnatally, Pax3 has been shown to be transiently
expressed during satellite cell (SC) activation to promote prolifer-
ation and inhibit differentiation (Boutet et al., 2007, 2010) of a
highly proliferative intermediate progenitor cell population
(Conboy and Rando, 2002). During the subsequent myogenic
differentiation, Pax3 is downregulated both at the protein level
by monoubiquitination and proteasomal degradation (Boutet
et al., 2007, 2010) and at the RNA level by at least two micro-CRNAs (miRNAs) (Crist et al., 2009; Hirai et al., 2010). However,
postnatal regenerative myogenesis appears to be normal in
mice in which Pax3 is conditionally deleted in SCs (Lepper
et al., 2009). Therefore, the contexts in which Pax3 may regulate
adult muscle stem and progenitor functions remain to be
elucidated.
Interestingly, SCs exhibit heterogeneity in terms of Pax3
expression in quiescence (Montarras et al., 2005; Relaix et al.,
2006), a difference that cannot be explained by differences in
protein stability (Boutet et al., 2010). Whereas virtually all quies-
cent SCs (QSCs) in most hindlimbmuscles do not express Pax3,
those in the diaphragm, ventral trunk muscles, and body wall
muscle (e.g., serratus caudalis dorsalis), specific hindlimb
muscles (e.g., gracilis), and about 50% of the forelimb muscles
do express Pax3 (Montarras et al., 2005; Relaix et al., 2006).
Remarkably, when Pax3+ve SCs are engrafted into the tibialis
anterior (TA) muscle where the resident SCs do not express
Pax3, they retain Pax3 expression, suggesting that Pax3 expres-
sion may be cell autonomous (Montarras et al., 2005). Prolifer-
ating progeny of Pax3+ve and Pax3ve SCs behave similarly in
in vitro assays of differentiation (Montarras et al., 2005; Relaix
et al., 2006). Overall, the mechanisms that differentially regulate
Pax3 expression in the different SC populations remain to be
determined as does the functional significance of Pax3 expres-
sion in the quiescent state. Given the fact that the Pax3 transcript
is expressed in limb SCs that do not express the Pax3 protein,
posttranscriptional regulation likely accounts for some of the
spatial and temporal heterogeneity of Pax3 expression.
Several muscle-specific miRNAs have been shown to be
important posttranscriptional regulators of different aspects of
the myogenic program (Chen et al., 2006; Rao et al., 2006;
Sweetman et al., 2008). Analysis of the 30UTR of the Pax3 gene
revealed target sites for miRNA-206 (miR-206) (Goljanek-
Whysall et al., 2011; Hirai et al., 2010) and miRNA-27b (miR-
27b) (Crist et al., 2009). miR-206 is a skeletal-muscle-specific
miRNA in mice (Kim et al., 2006), and its expression is regulated
by the myogenic regulatory factors MyoD, Myf5, and Myogenin
(MyoG) (Rao et al., 2006; Sweetman et al., 2008). miR-206 pro-
motes terminal differentiation of myogenic progenitors by inhib-
iting the expression of the p180 subunit of DNA polymerase a as
well as Id1-3 and MyoR (Kim et al., 2006). Pax3 and Pax7 are
targeted by miR-206 and miR-1 during terminal differentiation
of SC-derived myoblasts to enforce the differentiation program
(Chen et al., 2010; Hirai et al., 2010). Likewise, miR-206 andell Stem Cell 10, 327–336, March 2, 2012 ª2012 Elsevier Inc. 327
10
15
m
iR
-2
06
 L
ev
el
0 5
1.0
1.5
ax
3 
m
R
N
A
 le
ve
ls
A B
** **
Control
miR 1
QSC Mb
0
5
R
el
at
iv
e 
QSC Mb
0.0
.
R
el
at
iv
e 
P
a
DC
0.6
0.8
1.0
1.2
1.4
Anti-miR-1
Anti-miR-206
ax
3 
m
R
N
A
 le
ve
ls
0.6
0.8
1.0
1.2
1.4
-
miR-206
e 
m
R
N
A
 le
ve
ls
*
**
N S
N.S.
**N.S.
N.S.
N.S.
Day 0 Day 1 Day 2
0.0
0.2
0.4
R
el
at
iv
e 
P
a
Pax3 Pipb
0.0
0.2
0.4
R
el
at
iv
e
Relative luciferase activityE
. .
0.0 0.5 1.0
2061 2062
LucWT
WT
m1
A(n)
A(n)Luc X
Luc A(n)
miR-206
-
+
+
*
N.S.
N.S.
*
0.0 0.5 1.0 1.5
Relative luciferase activityF
m2
m1+m2
A(n)Luc X
A(n)Luc XX
+
+
G
2061 2062
Luc
Empty
WT
m1
A(n)
A(n)Luc X
( )
Luc A(n)
WT
m1
+ m2
Pax3
GAPDH
5 5 2 1µg
*
N.S.
N.S.
*
m2
m1+m2
A nLuc X
A(n)Luc XX
Figure 1. miR-206 Is Highly Expressed in QSCs and Regulates Pax3 Transcript in SCs
(A and B) Quantitative RT-PCR analysis of Pax3 mRNA (A) or miR-206 (B) levels in QSCs sorted from uninjured muscle and from myoblasts (Mb) sorted from
injured muscle 3.5 days after BaCl2 injection.
(C) Quantitative analysis ofmRNA levels of Pax3 andCyclophilin B (Pipb) in primarymyoblast cultures treatedwithmiR-1 (black) ormiR-206 (white) in growthmedium.
(D) Quantitative analysis of Pax3mRNA in primarymyoblast cultures treated with anti-miR-1 (black) or anti-miR-206 (white) and cultured in differentiation medium
for 1 or 2 days.
(E) Luciferase reporter assays showing the long form of Pax3 30UTR repression by miR-206 in HEK293 cells. Luciferase constructs and miR-206-expressing
plasmids were cotransfected in HEK293 cells, and luciferase activity was measured 48 hr posttransfection. Mutation of both target sites is necessary to abolish
the repression of luciferase activity by miR-206 (m1+m2).
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Alternative Polyadenylation and Stem Cell FunctionmiR-1 target Pax3 to promote differentiation of embryonic
myogenic progenitors during development (Goljanek-Whysall
et al., 2011). To date, no miRNAs have been shown to regulate
the early stages of activation of QSCs.
In this report, we show that miR-206 is unexpectedly highly
expressed in QSCs where it regulates the expression of Pax3.
We further show that QSCs in different muscles differentially
process the Pax3 transcript through alternative polyadenylation
to yield transcripts with different 30UTR lengths, rendering them
differentially susceptible to miR-206 regulation. This results in
markedly different levels of Pax3 protein expression and a clear
functional change in muscle progenitor behavior. Our results
suggest that alternative polyadenylation is an important process
involved not only in the modulation of miRNA regulation but also
in the control of stem cell function and in the determination of
stem cell heterogeneity.
RESULTS
miRNA-206 Is Highly Expressed in Adult Muscle Stem
Cells
Pax3 transcript is present inQSCs from limbmuscles, despite the
absence of detectable protein (Figure 1A). Although there is
a transient increase in Pax3 protein during SC activation (Conboy
and Rando, 2002), both transcript and protein levels decline
during the progression to fusion-competent myoblasts (Boutet
et al., 2007 and Figure 1A). Because of the discordance between
Pax3 transcript and protein levels in limbQSCs,we hypothesized
that Pax3 might be regulated posttranscriptionally by miRNAs in
QSCs (Figure S1A available online). Indeed, we found that miR-
206 is expressed at high levels in QSCs and increases even
further during SC activation (Figure S1B, Figure 1B). By contrast,
miR-1 (which has the same seed sequence as miR-206) and
miR-27b are expressed at a much lower level in QSCs (Fig-
ure S1B). Thus, we explored the role of miR-206 in the regulation
of Pax3 expression in QSCs and progenitor cells postnatally.
miRNA-206 Regulates Pax3 In Vitro
To test whether Pax3 is posttranscriptionally regulated by miR-
206, we performed quantitative RT-PCR analysis in primary
myoblasts transfected with miR-206. As a control we used
miR-1, another miRNA expressed in differentiating myoblasts
(Kim et al., 2006; Rao et al., 2006) that contains the same seed
sequence as miR-206 (Figure S1C). Pax3 mRNA levels were
reduced in cells treated with miR-206 but not in cells treated
with miR-1 (Figure 1C). To test whether endogenous miR-206
controls Pax3 transcript levels, we assessed Pax3 levels in cells
treated with anti-miR-206 during myogenic differentiation, when
the levels of Pax3 transcript decline precipitously (Boutet et al.,(F) Luciferase reporter assays showing the long form of Pax3 30UTR repression b
constructs, C2C12 cells were cultured in differentiationmedium for 48 hr to allow e
abolish the repression of luciferase activity by miR-206 (m1+m2). Pax3 murine lo
constructs are indicated on the left of the graphs (WT, m1, m2, m1+m2). miR-206 c
indicated.
(G) Competitive inhibition of miR-206 using the Pax3 30UTR construct. Immunob
transfection with luciferase constructs containing either wild-type or mutated mi
Pax3 transcript by miR-206 was rescued by the overexpression of wild-type Pax3
N.S., not significant; n = 3).
See also Figure S1.
C2007). After 24 and 48 hr in differentiation medium, Pax3
mRNA levels were maintained at high levels in cells treated
with anti-miR-206, but not in those treated with anti-miR-1 (Fig-
ure 1D, Figure S1D). These results suggest that miR-206 is an
endogenous regulator of Pax3 transcript levels. Consistent
with previous studies in proliferative myoblasts (Chen et al.,
2010), we found that Pax7 transcript levels, which are high in
QSCs, were also reduced by miR-1 and miR-206 but, unlike
Pax3, Pax7 was more susceptible to miR-1 than to miR-206
treatment (Figures S1E and S1F).
To analyze the functional roles of the two putative miR-206
target sites, we introduced the Pax3 30UTR downstream of a
luciferase reporter gene. We then generated Pax3 30UTR con-
structs containing a mutation in either or both miR-206 target
sites. To abolish miR-206 pairing, point mutations were intro-
duced in the putative target sites at the bases corresponding
to positions 2 and 4 of the miR-206 seed sequence (Figure S1C).
In HEK293 cells, which do not express Pax3, miR-1, or miR-206,
we cotransfected either miR-1 or miR-206 with each of the
reporter constructs. miR-206, but not miR-1, reduced luciferase
expression from the wild-type reporter and from reporter
constructs bearing single miR-206 target site mutations with
equal efficacy (Figure 1E, Figure S1G). However, when miR-
206 was cotransfected with the reporter bearing mutations in
both target sites, the level of luciferase expression was identical
to that in cells transfected with no miRNA. Using these con-
structs, we observed the same results in C2C12 cells undergoing
differentiation (Figure 1F), when endogenous miR-206 is highly
induced (Figure S1H). Taken together, these results suggest
that Pax3 mRNA is targeted by miR-206 and that either of the
two 30UTR sites is sufficient to mediate the downregulation of
Pax3 transcript.
To test further whether endogenous miR-206 regulates
endogenous Pax3 protein levels, we reduced miR-206 in SC-
derived myoblasts by transfecting constructs expressing the
Pax3 30UTR to sequester endogenous miR-206 (Ebert et al.,
2007). Indeed, in the presence of this miR-206 ‘‘sponge,’’ Pax3
protein levels increased in a dose-dependent fashion (Figure 1G).
By contrast, Pax3 protein levels did not change in cells trans-
fected with a construct expressing the Pax3 30UTR in which
both miR-206 target sites had been mutated. These results
demonstrate that Pax3 protein level is regulated posttranscrip-
tionally by miR-206 in a dose-dependent manner.
miRNA-206 Regulates Pax3-Mediated Functions
in Adult Muscle Stem Cells Ex Vivo
As previously reported by our group and others, Pax3 enhances
proliferation and prevents differentiation of SCs (Boutet et al.,
2007, 2010; Crist et al., 2009). In order to assess the functionaly miR-206 in C2C12 cells after differentiation. After transfection with luciferase
ndogenousmiR-206 upregulation. Mutation of both target sites is necessary to
ng 30UTR was appended to the luciferase ORF (Luc). The different luciferase
omplementary sites (2061 and 2062) (vertical line) andmutated sites (cross) are
lot analysis of Pax3 protein level in satellite-cell-derived myoblasts, 48 hr after
R-206 target sites, cultured in differentiation medium, is shown. Repression of
30UTR construct, which acts as a competitive inhibitor (*p < 0.05; **p < 0.001;
ell Stem Cell 10, 327–336, March 2, 2012 ª2012 Elsevier Inc. 329
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Alternative Polyadenylation and Stem Cell Functionrelevance of miR-206 regulation of Pax3, wemodulated the level
of miR-206 in SCs ex vivo. We transfected SCs associated with
single fibers with miR-206, anti-miR-206, Pax3 siRNA, or control
miRNA (Figure 2A). To detect SCs on single fibers, we analyzed
the expression of Syndecan4, which has been shown to be
specific for QSCs in single fiber explants (Cornelison et al.,
2001) and for activated SC progeny in regenerating muscle (Le
Grand et al., 2009; Tanaka et al., 2009). SCs were transfected
very efficiently as shown with Cy3-labeled oligonucleotides
(Figure S2A). Compared to control, treatment of limb SCs with
miR-206 resulted in a significantly reduced number of activated
cells (Figure 2A; and see Figure 3D, left panel). Conversely, trans-
fection of SCs with anti-miR-206 resulted in an increase in the
proliferative expansion of the population (Figure 2A and Fig-
ure 3D, left panel). The increased proliferation observed in fiber
cultures treatedwith anti-miR-206was abrogated by cotransfec-
tionwithPax3 siRNA (Figure 2B), suggesting that the regulation of
cell proliferation by miR-206 occurs through the inhibition of
Pax3. Although the proliferative expansion of SCs was inhibited
by treatment with miR-206, it did not prevent SCs from breaking
quiescence and entering the cell cycle, as evidenced by the
incorporation of EdU, a process that was only enhanced by treat-
ment with anti-miR-206 (Figure S2B). Given the fact that Pax7 is
targeted by miR-206 to regulate myoblast differentiation (Chen
et al., 2010), we tested whether Pax7 was contributing to the
regulation of SC activation and proliferative expansion. As
such, we transfected SCs associated with single fibers with
Pax7 siRNA. Compared to control, treatment of limb SCs with
Pax7 siRNA did not result in any significant change in SC activa-
tion and proliferation (Figures S2C and S2D). These results
suggest that miR-206 controls proliferation during SC activation
by regulating Pax3 levels and that Pax7, although a target of
miR-206, does not play a major role in these processes.
Overexpression of miR-206 also significantly increased the
proportion of cells undergoing myogenic lineage progression
and differentiation as determined by high levels of MyoD or
MyoG expression, respectively, whereas treatment with anti-
miR-206 had the opposite effects (Figures 2C and 2D, Figures
S2E and S2F). Maintenance of cells in an undifferentiated state
(MyoDve/MyoGve) by anti-miR-206 was mediated by sus-
tained Pax3 level since the effect could be abolished by cotrans-
fection of Pax3 siRNA with anti-miR-206 (Figure 2E). Together,
these results suggest that miR-206 strongly represses Pax3 in
limb SCs, limits its ability to enhance proliferation, and delays
myogenic differentiation in adult muscle stem cells.
Downregulation of miR-206 Increases Pax3 Protein
and Pax3-Mediated Functions in Limb SCs In Vivo
To test for the regulation of Pax3 by miR-206 in limb SCs in vivo,
we administered miR-206 antagomirs to 8-week-old mice by tail
vein injection. We then assessed Pax3 protein expression in
purified limb SCs and the proliferative expansion comparing SCs
from extensor digitorum longus (EDL) muscles of antagomir-
treated and control mice. After a single miR-206 antagomir
injection, SCs were purified by FACS and subject to western
blot analysis. Higher levels of Pax3 protein were detected in
SCs from antagomir-treated mice, suggesting that miR-206
suppresses endogenous Pax3 protein level in QSCs (Figure 2F).
When SC proliferation from antagomir-treated mice was330 Cell Stem Cell 10, 327–336, March 2, 2012 ª2012 Elsevier Inc.analyzed ex vivo, more SCs were found on single fibers 3 days
after isolation (Figure 2G), although no significant difference in
SCs was observed in freshly isolated fibers at day 0. This was
also associated with an inhibition of myogenic commitment
and differentiation in the population (Figure 2H). Therefore,
downregulation of miR-206 by anti-miR-206 treatment in vivo
leads to increased Pax3 protein in QSCs and subsequent
increased Pax3-mediated progenitor proliferation.
Pax3 Transcripts Are Not Susceptible to miRNA-206
in Diaphragm SCs
These data indicate that miR-206 is a physiological regulator of
Pax3 expression. As such, we hypothesized that different
expression patterns of miR-206 in other myogenic stem cells
or progenitors would account for patterns of Pax3 expression
that differ from those in limbmuscle SCs.We therefore examined
the relationship between Pax3 and miR-206 expression in two
distinct populations of adult SCs—those that express Pax3
protein in the quiescent state, such as SCs in the diaphragm
muscle, and those that do not, such as SCs in nearly all limb
muscles (Montarras et al., 2005; Relaix et al., 2006). Indeed,
we found that Pax3 transcript and protein levels were much
greater in SCs from diaphragm compared to limb SCs (Fig-
ure 3A). Consistent with this observation, knockdown of Pax3
in diaphragm SCs inhibited proliferative expansion much more
than in limb SCs (Figure 3B). However, although we predicted
that the higher level of Pax3 transcript would be associated
with a lower level of miR-206 expression in SCs of the diaphragm
compared to the limb, we were surprised to discover that miR-
206 was expressed in similar levels in SCs from both muscles
(Figure 3C). To test whether miR-206 regulates Pax3 levels in
diaphragmSCs as it does in limb SCs, we compared proliferative
expansion of limb and diaphragm SCs treated with miR-206
and anti-miR-206. Surprisingly, unlike in limb SCs, increasing
or decreasing miR-206 levels had a negligible effect on Pax3-
mediated proliferation of SCs from the diaphragm (Figure 3D).
Likewise, miR-206 had less effect on SCs from the diaphragm
than those from limbmuscles in terms of inhibiting differentiation
(Figures S3A–S3D; compare to Figures 2C and 2D). Thus, Pax3
transcript in diaphragm SCs appeared not to be subject to
regulation by miR-206.
Alternative Polyadenylation Allows Pax3 Transcripts
to Escape miR-206 Targeting in Diaphragm Muscle
Stem Cells
To address this conundrum of the apparent lack of regulation of
Pax3 by miR-206 in diaphragm SCs, we examined the Pax3
30UTR in more detail. Interestingly, four putative polyadenylation
signals (PAS) were identified at positions 345, 612, 1723, and
2019 in the 30UTR downstream from the stop codon. Impor-
tantly, the Pax3 transcript could contain both or neither of the
miR-206 target sites depending on the selection of PAS (Fig-
ure 4A). We performed 30 rapid amplification of cDNA ends
(RACE) and confirmed that three PASwere functional (Figure 4B).
The longest form (PAS at position 2019) contained both miR-206
target sites, whereas the shorter forms (PAS at position 345 or
612) contained neither (Figure 4A). As such, the long form would
be susceptible to miR-206 regulation, whereas the short forms
would be resistant. We performed quantitative RT-PCR using
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Figure 2. miR-206 Regulates Pax3-Mediated Proliferation and Myogenic Lineage Progression during Adult Myogenesis Ex Vivo and In Vivo
(A) Low magnification (103) images of single fibers treated with control miRNA, anti-miR-206, miR-206, or Pax3 siRNA, and stained for Syn4 (green) and DAPI
(blue) 3 days after isolation (bar: 40 mm).
(B) Number of Syn4+ve cells counted on single fiber explants cultured for 3 days. Fibers were treated with control, anti-miR-206 with control siRNA, or anti-
miR-206 with Pax3 siRNA.
(C and D) Quantitative analysis of MyoG (C) or MyoD (D) expression in Syn4+ve SCs per fiber in single fiber explants treated with control miRNA, miR-206,
anti-miR-206, or Pax3 siRNA, and cultured for 3 days.
(E) Quantitative analysis of MyoD expression in Syn4+ve SCs per fiber in single fiber explants treated with anti-miR-206 with either Control or Pax3 siRNA.
(F) Western blot analysis of QSCs from limb muscle (except extensor digitorum longus; EDL) in mice injected with control antagomirs (Control) or anti-miR-206
antagomirs (Antagomir-206).
(G) Number of Syn4+ve cells counted on EDL single fiber explants frommice injected with control antagomir (Control) or anti-miR-206 antagomir (Antagomir-206)
and cultured for 3 days.
(H) Quantitative analysis of MyoD expression in Syn4+ve SCs per fiber on single fiber explants (EDL) from mice injected with control antagomirs (Control) or
anti-miR-206 antagomirs (Antagomir-206) and cultured for 3 days. (Line indicates mean; *p < 0.01; **p < 0.0001; N.S., not significant; n = 51).
See also Figure S2.
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Figure 3. Pax3 mRNA Is Not Susceptible to miR-206 Regulation in Diaphragm SCs
(A) Western blot analysis of Pax3 protein level (left) and quantitative RT-PCR analysis of Pax3 mRNA level (right) in QSCs from limb (L) and diaphragm (D) muscles
(n = 3).
(B) Number of Syn4+ve cells counted on single fiber explants from limb and from diaphragm cultured for 3 days. Fibers were treated with control or Pax3 siRNA.
(Line indicates mean, n = 51).
(C) Quantitative RT-PCR analysis of miR-206 level in QSCs from limb (L) and diaphragm (D) muscles (n = 3).
(D) Number of Syn4+ve cells counted on single fiber explants from limb (EDL) and fromdiaphragm cultured for 3 days. Fibers were treatedwith control, miR-206, or
anti-miR-206. (Line indicates mean; *p < 0.05, **p < 0.0001; n = 51).
See also Figure S3.
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Alternative Polyadenylation and Stem Cell FunctionTaqman probes specific to the longest and shortest forms of the
30UTR to determine their relative abundance (Figures S4A and
S4B). In limb SCs, the long form of the Pax3 transcript, suscep-
tible to miR-206 regulation, was the predominant form ex-
pressed (Figure 4C). By contrast, the short form that lacks the
miRNA-206 sites was abundantly expressed in diaphragm SCs
(Figure 4C). Therefore, these data suggested that diaphragm
SCs are able to express Pax3 at high levels even in the presence
of high levels of miR-206 because the form of the Pax3 transcript
that is expressed is not susceptible to regulation by miR-206 by
virtue of choice of PAS, resulting in 30UTR without any known
miRNA target sites.
Alternative Polyadenylation Allows Pax3 Transcripts
to Escape miR-206 Targeting in Embryonic Progenitors
We hypothesized that early embryogenesis might represent
another context in which the regulation of Pax3 by miR-206 in
myogenic progenitors is determined by 30UTR length. Between
E10.5 and E15.5, there is only a gradual decline in Pax3 expres-
sion in myogenic progenitors, particularly with high sustained332 Cell Stem Cell 10, 327–336, March 2, 2012 ª2012 Elsevier Inc.levels through E10.5 and E11.5 (Figure S4C), despite an expo-
nential increase in the expression of miR-206 (Figure S4D). As
such, we analyzed the relative abundance of short and long
forms of Pax3 30UTR at these different stages. Indeed, the short
form was the predominant form expressed at E10.5 and E11.5,
representing 80% of the total at both time points and still
representing 50% of the total at E15.5 (Figure 4D). Thus, in
embryonic progenitors as in diaphragm SCs, the expression of
Pax3 with a short 30UTR allowed for persistently high levels of
Pax3 protein expression despite exponential increases in
miR-206 expression (Figure 3A). To test this directly, we trans-
fected miR-206 into E10.5 progenitors and analyzed the levels
of Pax3 expression. Aswith SCs from diaphragm, the expression
of Pax3 in embryonic progenitors was negligibly affected by high
levels of miR-206, whereas Pax3 siRNA knocked down Pax3
transcript to 30% of control levels (Figure 4E). Taken together,
our data indicate that miR-206 targets and downregulates the
Pax3 transcript in adult SCs from limb muscles, but has negli-
gible effects on embryonic muscle progenitors as well as SCs
from the diaphragm.
A 
PAS
2
2061
PAS
4
UAG
2062
PAS
1
| | | | |
345         612                                      1723       2019
PAS
3
A(n)PAS1 (345)B
0       500     1000      1500    2000
                                                                                              
PAS2 (612) A(n)
PAS4 (2019) A(n)
1.0
1.2
nd
C **
L D
0.0
0.2
0.4
0.6
0.8 long
short
P
ro
po
rt
io
n 
of
 lo
ng
 a
n
sh
or
t P
ax
3 
3'
U
T
R
0 6
0.8
1.0
1.2
1.4
short
long
 o
f l
on
g 
an
d
ax
3 
3'
U
T
R
0.6
0.8
1.0
1.2
3 
m
R
N
A
 le
ve
ls
D E N.S.
*
N.S.
N.S.
E10.5 E11.5 E15.5
0.0
0.2
0.4
.
P
ro
po
rt
io
n
sh
or
t P
a
Co
nt
ro
l
m
iR
-2
06
Pa
x3
 si
RN
A
0.0
0.2
0.4
R
el
at
iv
e 
P
ax
3
Figure 4. Differential Polyadenylation of Pax3
mRNA 30UTR in Limb and Diaphragm QSCs and in
Embryonic Limb Progenitors
(A) Graphical representation indicating the positions of the
putative alternative polyadenylation sites (PAS1, PAS2,
PAS3, and PAS4) and putative miR-206 targeted sites
(2061 and 2062) in the Pax3 3
0UTR.
(B) DNA sequencing of 30UTRs of three different isoforms
of Pax3 detected by 30 RACE. PAS consensus sequence
(PAS) and polyadenylation tail region (A(n)) are indicated.
(C) Quantitative RT-PCR analysis of Pax3 transcripts
bearing short and long 30 UTRs in limb (L) and in diaphragm
(D) QSCs.
(D) Ratios of long and short Pax3 mRNA isoforms in limb
buds at E10.5 and E11.5. In (C) and (D), the proportions of
the short form in L and D were compared.
(E) Quantitative RT-PCR analysis of Pax3 mRNA levels
in E10.5 myogenic progenitors treated with control or
miR-206. Pax3 siRNA was used as a positive control (**p <
0.001; N.S., not significant; n = 3).
See also Figure S4.
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Our results provide a molecular mechanism underlying the
heterogeneity of SCs with regard to Pax3 expression in theCell Stem Cell 10,quiescent state. SC heterogeneity has been
described based on functional characteriza-
tions including developmental origin, functional
characteristics, and properties of associated
myofibers (Biressi and Rando, 2010). Our
studies shed light on the peculiar heterogeneity
of SCs in terms of Pax3 expression, which does
not follow any known physiological, structural,
or developmental pattern. Pax3+ve SCs are
observed in hindlimb gracilis muscle, in about
50% of forelimbmuscles, in subsets of the trunk
muscles, and in the diaphragm (Relaix et al.,
2006). Interestingly, Pax3 expression is pre-
served when Pax3+ve SCs are transplanted
into Pax3ve limb muscle, suggesting that
Pax3 expression is cell autonomous (Montarras
et al., 2005). Our data present evidence of a
molecular mechanism, based on the propensity
of certain SCs to produce different Pax3
transcripts through alternative polyadenylation
(APA), underlying any functional heterogeneity.
One interesting aspect of our data is the finding
that different ratios of Pax3 transcript variants
with regard to 30UTR length are found in
different muscle precursor populations. Clari-
fying whether the observation of different ratios
of Pax3 isoforms is due to molecular heteroge-
neity in individual cells or cellular heterogeneity
within the population (with molecular homoge-
neity within individual cells) will necessarily
await analysis of Pax3 isoforms on a single-
cell level.
Almost all eukaryotic mRNAs are polyadeny-
lated through a process that involves cleavageat a specific site followed by the synthesis of a polyA tail (Lutz,
2008; Maniatis and Reed, 2002), and more than half of the
mammalian genes generate transcripts that are subjected to
APA (Tian et al., 2005). While several studies have examined327–336, March 2, 2012 ª2012 Elsevier Inc. 333
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Alternative Polyadenylation and Stem Cell Functionpolyadenylation signals and patterns, the molecular mecha-
nisms involved in the choice of polyadenylation sites are poorly
understood (Licatalosi and Darnell, 2010; Lutz, 2008; Millevoi
and Vagner, 2010; Zhao et al., 1999). Three types of APA (I, II,
and III) have been defined with regard to the location of the
different PAS and whether the APA is coupled with an alternative
splicing (Lutz, 2008; Millevoi and Vagner, 2010; Zhao et al., 1999;
Edwalds-Gilbert et al., 1997). In human and mouse cells, Pax3
transcripts display a complex pattern of alternative splicing
with at least eight different transcript variants reported (Barber
et al., 1999; Pritchard et al., 2003; Wang et al., 2006; Parker
et al., 2004). Considering the complex alternative splicing of
Pax3 transcripts, it is likely that Pax3 APA falls into the type III
category in which splicing events affect the 30 end processing
of Pax3 mRNA.
The importance of APA for regulation of protein expression,
and the fact that APA may also be coordinated with alternative
promoter choice (Costessi et al., 2006;Winter et al., 2007), raises
fundamental questions about the extrapolation of endogenous
protein expression from transgenic reporter mice in which
endogenous PAS selection, splicing, and promoter choice may
be altered at the genomic level. For Pax3 reporter mice, the
temporal and spatial expression of the reporter exhibits both
concordant and discordant patterns compared with those re-
ported for the endogenous Pax3 protein (Boutet et al., 2007,
2010; Montarras et al., 2005; Relaix et al., 2006), including the
results reported here. Therefore, extrapolating the endogenous
gene expression levels, especially when multiple isoforms exist
with regard to different promoters and different 30UTRs, from
studies of knockin mice is risky because of the possibility of
disruption of regulatory mechanisms associated with the genetic
recombination associated with the knockin.
Our studies demonstrate that APA can lead to transcripts with
different 30UTR lengths even within a specific population of
quiescent stem cells. APA leading to longer or shorter 30UTR
lengths has recently been described as a more global phenom-
enon both in terms of transcripts affected (i.e., at the transcrip-
tome in general, not specific transcripts) and in terms of
biological context (e.g., during development, in cancer, and in
response to induction of proliferation) (Ji et al., 2009; Mayr and
Bartel, 2009; Sandberg et al., 2008). In these cases, specific
transcripts were not analyzed to assess the functional relevance
of global shortening or lengthening of 30UTRs, but it was postu-
lated that such changes could affect multiple aspects of
transcript function including localization, stability, and transla-
tion, some of which could be due to changes in miRNA targeting
as we have shown specifically here for Pax3 transcripts in QSCs.
Specific examples of APA leading to transcripts of specific
genes with different 30UTR lengths, rendering them more or
less susceptible to regulation by miRNAs, are just beginning to
be identified. In studies of the regulation of the Hsp70.3 gene
in the setting of cardiac ischemia, it was found that ischemic pre-
conditioning leads to APA of Hsp70.3 transcript, resulting in a
transcript with a shorter 30UTR and lacking a miR-378 target
site (albeit while still retaining a miR-711 target site) (Tranter
et al., 2011). The resulting transcript may allow for higher levels
of Hsp70.3 protein expression to promote protection from
ischemic damage. In the current study, we present evidence of
APA of a specific gene leading to shortened transcripts lacking334 Cell Stem Cell 10, 327–336, March 2, 2012 ª2012 Elsevier Inc.any knownmiRNA binding site and leading to functional changes
in stem cells that are determined specifically by PAS choice.
Studies of the regulation of Pax3 by miRNAs have yielded
divergent conclusions. Hirai et al. showed that miR-206, a direct
target of MyoD, controls the level of Pax3 expression to promote
myoblast survival (Hirai et al., 2010). Our study shows that while
miR-206 is significantly upregulated during myogenic differenti-
ation, it is also expressed at high levels in specific populations of
QSCs as well as in SC progeny and therefore plays a significant
role in SC activation prior to the onset of differentiation. miR-1
has been shown to downregulate Pax3 expression in myoblasts
and glioma cells (Goljanek-Whysall et al., 2011; Hirai et al., 2010).
However, neither we nor Crist et al. (2009) detected a downregu-
lation of Pax3 mRNA when miR-1 was overexpressed in SCs,
suggesting that the regulation of Pax3 expression by miR-1
may be limited to specific cell types and stages of the myogenic
program. Clearly, the quiescent state represents a unique cell
stage in which regulation by miRNAs may be distinct from the
regulation that occurs as a cell is undergoing terminal differenti-
ation. In that context, we have recently identified a miRNA,
miR-489, that is important for maintenance of SC quiescence
(Cheung et al., 2012).
Regulation of Pax3 expression by miRNAs has also been
studied in the context of development. Myogenic progenitors
during embryonic development express a high level of miR-
27b that also targets Pax3 (Crist et al., 2009). Overexpression
of miR-27b led to the downregulation of Pax3 and suppression
of Pax3-mediated migration and proliferation, resulting in
premature differentiation. Similarly, miR-206 was shown to
regulate Pax3 functions in the somite of the developing embryos
and was proposed to be required to stabilize myoblast commit-
ment and subsequent differentiation (Goljanek-Whysall et al.,
2011). Interestingly, overexpression of miR-27b was able to
reduce Pax3 expression by only about 50% (Crist et al., 2009),
consistent with our data that the short Pax3 isoform lacking
both miR-206 and miR-27b target sites represents 70% of the
total Pax3 transcripts in myogenic progenitors during this stage
of development. Our data highlights the importance of under-
standing the processing of transcript 30UTRs to be able to
understand both qualitatively and quantitatively the regulation
of that transcript by miRNAs. Certainly the differences that
underlie the variations in PAS choice and the resulting effect
on miRNA-mediated regulation of expression of a key myogenic
lineage gene suggests that the posttranscriptional regulation of
Pax3, even in the quiescent state, is part of an important regula-
tory network.EXPERIMENTAL PROCEDURES
Mouse Lines
C57BL6 mice were maintained in accordance with an approved Institutional
Animal Care and Use Committee protocol in accordance with the Veterinary
Medical Unit guidelines at VA Palo Alto Health Care Systems.
Satellite Cell Isolation
Hindlimb muscles or diaphragms were dissected, digested with collagenase
and dispase, and triturated. Mononucleated cells were stained with anti-
VCAM, anti-CD31, anti-CD45, and anti-Sca-1 antibodies (BD-PharMingen)
and sorted using a BD-FACS Aria II. To obtain activated SCs, TA muscles
were injured with BaCl2 before cell isolation.
Cell Stem Cell
Alternative Polyadenylation and Stem Cell FunctionPrimary Myoblast Cultures and Single Fiber Isolation
Primary myoblast cultures were isolated and maintained as previously
described (Quach and Rando, 2006). Single myofibers from extensor digito-
rum longus muscles or diaphragms were prepared as previously described
(Rosenblatt et al., 1995).
Quantitative RT-PCR and Analysis of APA Sites
Total RNA from SCs and embryonic tissues was extracted using Trizol reagent
(Invitrogen). For expression analysis, total RNA was reverse transcribed and
qPCR was carried out on a LightCycler 480 system (Roche) using Taqman
probes (Applied Biosystems). Relative quantification of gene expression
was carried out using the comparative CT method (Pfaffl, 2001). For 3
0UTR
quantification, reverse transcription was carried out with specific oligos for
short and long form UTRs. Absolute quantification of gene expression was
performed using standard curves to establish the amounts of long transcript
and total transcript. The amount of short transcript was obtained by substrat-
ing the amount of short transcript to the amount of long transcript. For the
identification of APA sites, total RNA was analyzed with SMARTer RACE
cDNA amplification kit (Clontech). Amplified fragments were subcloned into
pGEM-T-Easy (Promega) and sequenced.
cDNA Cloning and Constructs
Total RNA was extracted from primary myoblasts using TRIzol (Invitrogen).
Pax3 30UTR cDNA was generated with QIAGEN one-step RT-PCR Kit
(QIAGEN), subcloned into pGEM-T-Easy (Promega), and sequenced and
subcloned into pMIR-REPORT vector (Applied Biosystems). To disrupt miR-
206 binding sites, mutations were generated using the Quickchange PCR
directed mutagenesis Kit (Agilent).
miRNA and siRNA Transfection of Primary Myoblasts and Single
Fibers
Primary myoblasts or single fibers were transfected with 50 pmol of miRNA,
siRNA, or anti-miRNA. Primary cells were switched to differentiation medium
and harvested after 0, 24, or 48 hr while fibers were cultured for 72 hr and
then fixed.
Immunofluorescence and Quantitative Microscopy
Single fibers were fixed, permeabilized, blocked, and stained with either
anti-MyoD antibody (Dako) or anti-MyoG antibody (BD-Biosciences), and
anti-Syndecan4 antibody and 40-6-diamidino-2-phenylindole (DAPI). Imaging
was performed with a Zeiss Observer Z1 fluorescent microscope (Carl Zeiss).
Maximum pixel intensity in each cell was subtracted with the pixel intensity
on the supporting fiber. Threshold for low and high intensity was defined for
each cell.
Luciferase Assays
HEK293 cells were transfected with 30UTR luciferase, control Renilla, and
miRNA expression vectors and cultured for 24 hr. To study the effects of
endogenous miRNA on Pax3 30UTR, C2C12 cells were transfected with
30UTR luciferase and control Renilla vectors using Lipofectamine 2000
(Invitrogen) and cultured in differentiation medium. Cells were lysed and lucif-
erase activity was quantified with Dual Luciferase Assay System (Promega).
Limb Explants Culture and Transfection
Limb buds from E10.5 and E11.5 mouse embryos were placed in culture
medium, transfected with miR-206, Pax3, or control siRNA, and lysed in TRIzol
(Invitrogen).
In Vivo Antagomir Treatment
Synthetic anti-miR-206 and mutant anti-miR-206 antagomirs (ThermoFisher
Scientific) were administered by tail vein injection in CD1 mice. Hindlimb
muscles were harvested 4.5 days after injection for single fiber or SC isolation.
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